OPTION CARE HEALTH INC
OPCHNASDAQTrading Snapshot
- Day Range
- $31.25 โ $31.32
- 52-Week Range
- $18.01 โ $36.80
- Volume (shares)
- 144,139
- Avg Volume (shares)
- โ
- Shares Outstanding
- 149.8M
- Next Earnings
- 2026-11-04
Fundamentals Snapshot
- Annual Revenue
- $5.65B
- Last Q Revenue
- โ
- P/E Ratio
- 23.5
- P/S Ratio
- 0.8x
- EPS (TTM)
- $1.35
- Dividend Yield
- 0.00%
OPTION CARE HEALTH INC
OPCHFinancial history unavailable.
About OPTION CARE HEALTH INC
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
โLatest News & Updates
News unavailable.